Global health agencies announced Wednesday that generic versions of a groundbreaking injectable drug to prevent HIV will be made available from 2027 at around $40 a year in more than 100 low and middle-income countries, a move hailed as a potential gamechanger in the fight against the AIDS epidemic.
Disclaimer: The article linked is from a single source with a single perspective. Make sure to cross-check information against multiple sources to get a comprehensive view on the situation.